{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lipoprotéines LDL : Questions médicales les plus fréquentes",
"headline": "Lipoprotéines LDL : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lipoprotéines LDL : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-18",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lipoprotéines LDL"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipoprotéines",
"url": "https://questionsmedicales.fr/mesh/D008074",
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines",
"code": {
"@type": "MedicalCode",
"code": "D008074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cholestérol LDL",
"alternateName": "Cholesterol, LDL",
"url": "https://questionsmedicales.fr/mesh/D008078",
"about": {
"@type": "MedicalCondition",
"name": "Cholestérol LDL",
"code": {
"@type": "MedicalCode",
"code": "D008078",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.550.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines LDL",
"alternateName": "Lipoproteins, LDL",
"code": {
"@type": "MedicalCode",
"code": "D008077",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sotirios Tsimikas",
"url": "https://questionsmedicales.fr/author/Sotirios%20Tsimikas",
"affiliation": {
"@type": "Organization",
"name": "Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, University of California San Diego, La Jolla, California, USA."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Maija Ruuth",
"url": "https://questionsmedicales.fr/author/Maija%20Ruuth",
"affiliation": {
"@type": "Organization",
"name": "From the Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland (M.R., L.Ä., F.T.-S., P.T.K., K.Ö.)."
}
},
{
"@type": "Person",
"name": "Katariina Öörni",
"url": "https://questionsmedicales.fr/author/Katariina%20%C3%96%C3%B6rni",
"affiliation": {
"@type": "Organization",
"name": "From the Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland (M.R., L.Ä., F.T.-S., P.T.K., K.Ö.)."
}
},
{
"@type": "Person",
"name": "Jose L Flores-Guerrero",
"url": "https://questionsmedicales.fr/author/Jose%20L%20Flores-Guerrero",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Auditory central pathways in children and adolescents with multiple sclerosis.",
"datePublished": "2023-10-18",
"url": "https://questionsmedicales.fr/article/37852288",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1775985"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neural tracking as a diagnostic tool to assess the auditory pathway.",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36137861",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heares.2022.108607"
}
},
{
"@type": "ScholarlyArticle",
"name": "Aging process and central auditory pathway: a study based on auditory brainstem evoked potential and frequency-following response.",
"datePublished": "2022-05-27",
"url": "https://questionsmedicales.fr/article/35649058",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31744/einstein_journal/2022AO6829"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study of auditory pathways in type 1 diabetes mellitus through brainstem auditory evoked potentials and contralateral acoustic reflex.",
"datePublished": "2023-05-08",
"url": "https://questionsmedicales.fr/article/37194912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/2317-1782/20232021022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of auditory pathway by EABR before cochlear implantation and the postoperative effect analysis.",
"datePublished": "2022-05-31",
"url": "https://questionsmedicales.fr/article/35639140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00405-022-07458-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lipoprotéines",
"item": "https://questionsmedicales.fr/mesh/D008074"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lipoprotéines LDL",
"item": "https://questionsmedicales.fr/mesh/D008077"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lipoprotéines LDL - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lipoprotéines LDL",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lipoprotéines LDL",
"description": "Comment mesurer le taux de LDL ?\nQuels sont les niveaux normaux de LDL ?\nQuand faut-il vérifier le LDL ?\nQuels tests évaluent le LDL ?\nLe LDL peut-il être mesuré à domicile ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Auditory+Pathways#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lipoprotéines LDL",
"description": "Quels symptômes indiquent un taux élevé de LDL ?\nLe LDL affecte-t-il la peau ?\nLe LDL peut-il causer des crises cardiaques ?\nQuels signes d'alerte pour le cœur ?\nLe LDL est-il lié à l'AVC ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Auditory+Pathways#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lipoprotéines LDL",
"description": "Comment prévenir un taux élevé de LDL ?\nLe tabagisme influence-t-il le LDL ?\nLe stress affecte-t-il le LDL ?\nLes examens réguliers sont-ils importants ?\nL'hydratation influence-t-elle le LDL ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Auditory+Pathways#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lipoprotéines LDL",
"description": "Quels médicaments réduisent le LDL ?\nLes changements alimentaires aident-ils le LDL ?\nLe sport influence-t-il le LDL ?\nLes suppléments de phytostérols sont-ils efficaces ?\nLes traitements naturels existent-ils pour le LDL ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Auditory+Pathways#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lipoprotéines LDL",
"description": "Quelles sont les complications d'un LDL élevé ?\nLe LDL peut-il causer des maladies rénales ?\nLe LDL est-il lié à la démence ?\nComment le LDL affecte-t-il la circulation sanguine ?\nLe LDL peut-il affecter la vision ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Auditory+Pathways#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lipoprotéines LDL",
"description": "Quels sont les principaux facteurs de risque pour le LDL ?\nL'âge influence-t-il le LDL ?\nLe diabète affecte-t-il le LDL ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils le LDL ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Auditory+Pathways#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de LDL ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de LDL est mesuré par une analyse de sang après un jeûne de 9 à 12 heures."
}
},
{
"@type": "Question",
"name": "Quels sont les niveaux normaux de LDL ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux de LDL inférieur à 1,6 g/L est considéré comme normal pour la plupart des adultes."
}
},
{
"@type": "Question",
"name": "Quand faut-il vérifier le LDL ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de vérifier le LDL tous les 4 à 6 ans chez les adultes à risque normal."
}
},
{
"@type": "Question",
"name": "Quels tests évaluent le LDL ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le profil lipidique évalue le LDL, le HDL et les triglycérides dans le sang."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il être mesuré à domicile ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dispositifs de test à domicile peuvent mesurer le cholestérol, y compris le LDL."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un taux élevé de LDL ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé de LDL est souvent asymptomatique, mais peut mener à des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Le LDL affecte-t-il la peau ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépôts de cholestérol peuvent apparaître sur la peau, appelés xanthomes, en cas d'excès de LDL."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il causer des crises cardiaques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un taux élevé de LDL contribue à l'athérosclérose, augmentant le risque de crise cardiaque."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour le cœur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Essoufflement, fatigue excessive et douleurs dans le bras gauche peuvent signaler un problème cardiaque."
}
},
{
"@type": "Question",
"name": "Le LDL est-il lié à l'AVC ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un taux élevé de LDL augmente le risque d'accident vasculaire cérébral (AVC)."
}
},
{
"@type": "Question",
"name": "Comment prévenir un taux élevé de LDL ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, faire de l'exercice et adopter une alimentation équilibrée sont essentiels."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le LDL ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le LDL et diminue le HDL, augmentant le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le LDL ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à des niveaux élevés de LDL et à d'autres problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers aident à surveiller le taux de LDL et à prévenir les maladies."
}
},
{
"@type": "Question",
"name": "L'hydratation influence-t-elle le LDL ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hydratation est importante pour la santé globale, mais son effet direct sur le LDL est limité."
}
},
{
"@type": "Question",
"name": "Quels médicaments réduisent le LDL ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les statines sont couramment prescrites pour abaisser le taux de LDL dans le sang."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils le LDL ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fibres et faible en graisses saturées peut réduire le LDL."
}
},
{
"@type": "Question",
"name": "Le sport influence-t-il le LDL ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut aider à abaisser le LDL et améliorer le profil lipidique global."
}
},
{
"@type": "Question",
"name": "Les suppléments de phytostérols sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les phytostérols peuvent réduire le LDL lorsqu'ils sont intégrés à un régime alimentaire sain."
}
},
{
"@type": "Question",
"name": "Les traitements naturels existent-ils pour le LDL ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes comme l'ail et le thé vert peuvent aider à réduire le LDL, mais avec prudence."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'un LDL élevé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un LDL élevé peut entraîner des maladies cardiaques, des AVC et des problèmes vasculaires."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il causer des maladies rénales ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'athérosclérose due à un LDL élevé peut affecter la circulation sanguine vers les reins."
}
},
{
"@type": "Question",
"name": "Le LDL est-il lié à la démence ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent qu'un LDL élevé pourrait être associé à un risque accru de démence."
}
},
{
"@type": "Question",
"name": "Comment le LDL affecte-t-il la circulation sanguine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un LDL élevé peut provoquer des dépôts dans les artères, réduisant le flux sanguin et augmentant le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il affecter la vision ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de LDL peuvent contribuer à des problèmes oculaires, comme l'athérosclérose rétinienne."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le LDL ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme, une alimentation riche en graisses saturées et le manque d'exercice sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le LDL ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'avoir un LDL élevé augmente avec l'âge, surtout après 45 ans chez les hommes."
}
},
{
"@type": "Question",
"name": "Le diabète affecte-t-il le LDL ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le LDL et le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des niveaux élevés de LDL et à des problèmes de santé associés."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le LDL ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiaques peuvent augmenter le risque de LDL élevé."
}
}
]
}
]
}
From the Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland (M.R., L.Ä., F.T.-S., P.T.K., K.Ö.).
Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences (F.T.-S., R.K., K.Ö.), University of Helsinki, Finland.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Electronic address: mengxia45@163.com.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Electronic address: yongjunwang@ncrcnd.org.cn.
Multiple sclerosis (MS) is an inflammatory demyelinating disease. Auditory evoked potential studies have demonstrated conduction and neural processing deficits in adults with MS, but little is known a...
to evaluate the central auditory pathway with brainstem auditory evoked potentials (BAEP) and long-latency auditory evoked potentials (LLAEP) in children and adolescents with MS....
The study comprised 17 individuals with MS, of both sexes, aged 9 to 18 years, and 17 healthy volunteers, matched for age and sex. All individuals had normal hearing and no middle ear impairments. The...
Abnormal responses were observed in 60% of electrophysiologic assessments of individuals with MS. In BAEP, 58.82% of MS patients had abnormal responses, with longer wave V latency and therefore longer...
Children and adolescents with MS had abnormal BAEP responses, with delayed neural conduction between the cochlear nucleus and the lateral lemniscus. Also, abnormal LLAEP results suggest a decrease in ...
When a person listens to sound, the brain time-locks to specific aspects of the sound. This is called neural tracking and it can be investigated by analysing neural responses (e.g., measured by electr...
To analyze age-related changes in the central auditory pathway in healthy elderly individuals....
A prospective, quantitative cross-sectional study. The caseload comprised 18 adults (mean age, 22.78 years) and 18 elderly individuals (mean age, 66.72 years) of both sexes, who met inclusion criteria...
Elderly individuals had higher wave and interpeak latencies (waves I, III and V and interpeaks I-V and III-V) of brainstem auditory evoked potential. Latencies of frequency following response waves A,...
Brainstem auditory evoked potential and frequency-following response allowed appropriate assessment of age-related changes in the auditory pathway. Slower neural response to auditory stimuli suggests ...
To investigate the functionalities of the neural pathways through the auditory evoked potentials of the brainstem and the contralateral stapedial acoustic reflexes in normal-hearing individuals with t...
This is a cross-sectional study with a comparison group and a convenience sample, consisting of 32 individuals with type 1 diabetes mellitus and 20 controls without the disease. All subjects had heari...
The auditory thresholds of the acoustic reflex were statistically lower in the group with the disease at frequencies of 0.5 kHz and 1.0 kHz in the left ear (p=0.01 and p=0.01, respectively). The absol...
The findings suggest that subjects with type 1 diabetes mellitus are more likely to present alterations in the central auditory pathways, even with auditory thresholds within normal limits....
To investigate the evaluation value of electrically evoked auditory brainstem response (EABR) monitoring before cochlear implantation in patients with cochlear nerve defects (CND)....
A total of 54 patients with cochlear nerve defects who underwent cochlear implantation in our hospital from 2011 to 2018 were selected as the CND group, and 20 patients with normal cochlear implantati...
The EABR waveform of the CND group was significantly different from the control group in terms of average wave V threshold, average dynamic range and V-wave I/O curve slope (P < 0.05). Average C value...
The EABR test can be used to evaluate the auditory pathway function before cochlear implantation and its postoperative effect in patients with CND....
To characterize the peripheral and central auditory pathways in individuals with Acute Lymphoid Leukemia (ALL) and compare assessment results before and during chemotherapy....
The study included 17 subjects with ALL, divided into two age groups: 3 to 6 (11 individuals) and 7 to 16 years old (6 individuals). Each subject was evaluated twice (before and 3 to 6 months after ch...
PTA was normal. Tympanometry was abnormal in the second assessment in 2 individuals aged 3 to 6 years. One subject in each age group had absent ipsilateral acoustic reflexes. In high-frequency audiome...
No hearing loss was identified in the behavioral audiological assessment. BAEP was more affected in the 3-to-6-year-old group, with greater impairment in the lower brainstem in the first and second as...
Congenital cytomegalovirus infection (cCMVi) is a leading cause of sensorineural hearing loss (SNHL) and developmental delay. Brainstem auditory evoked potentials (BAEPs) recording allows assessment o...
As the world becomes more urbanized, more people become exposed to traffic and the risks associated with a higher exposure to road traffic noise increase. Excessive exposure to environmental noise cou...
The human auditory system extracts rich linguistic abstractions from speech signals. Traditional approaches to understanding this complex process have used linear feature-encoding models, with limited...
Subjective promontory stimulation is used to evaluate cochlear implant (CI) candidacy, but the test reliability is low. Electrically evoked auditory brainstem response (EABR) can verify the function o...
We hypothesised that LA-TT-EABR waveforms of good quality would be related to successful hearing outcomes. We assumed that the duration of hearing loss/deafness was a confounding factor to study outco...
19 borderline CI candidates....
Positive LA-TT-EABR results were confirmed in 14 patients. LA-TT-EABR's mean latency was 2.05 ± 0.31 ms (eII/eIII) and 4.24 ± 0.39 ms (eIV/eV). Latencies weren't statistically different from intra-ope...
LA-TT-EABR is a tool in the frame of pre-operative objective testing the auditory pathway. It seems useful for clinical testing CI candidacy. Based on this study's outcomes, LA-TT-EABR should be recom...